• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

47.18 +0.30 (+0.64%)
Official Closing Price Updated: 7:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,686,978
Open 46.99
Bid (Size) 47.15 (2)
Ask (Size) 47.22 (2)
Prev. Close 46.88
Today's Range 46.82 - 47.36
52wk Range 42.96 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cytokinetics And The 'Provocative Conversation' That Could Rewrite Heart Disease
August 30, 2025
Cytokinetics said Saturday its experimental treatment for a progressive heart disease outperformed standard beta blockers. 
Via Investor's Business Daily
Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025
August 29, 2025
From Bristol Myers Squibb
Via Business Wire

Performance

YTD
-16.9%
-16.9%
1 Month
+8.9%
+8.9%
3 Month
-3.3%
-3.3%
6 Month
-21.2%
-21.2%
1 Year
-5.5%
-5.5%

More News

Read More
Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 29, 2025
From Bristol Myers Squibb
Via Business Wire
Price Over Earnings Overview: Bristol-Myers Squibb
August 18, 2025
Via Benzinga
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
August 27, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Branded Pharmaceuticals Stocks Q2 Recap: Benchmarking Bristol-Myers Squibb (NYSE:BMY)
August 26, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
1 Profitable Stock Worth Investigating and 2 We Turn Down
August 26, 2025
Via StockStory
Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025
August 25, 2025
From Bristol Myers Squibb
Via Business Wire
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock with Strong Profitability and Growth Prospects
August 25, 2025
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
August 22, 2025
Via Benzinga
ServiceNow, Live Nation Entertainment And A Health Care Stock: CNBC's 'Final Trades'
August 22, 2025
Via Benzinga
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Identified as a Top Value Stock with Strong Fundamentals
August 22, 2025
Via Chartmill
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
August 19, 2025
Via Benzinga
How Do Investors Really Feel About Bristol-Myers Squibb?
August 19, 2025
Via Benzinga
Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS
August 16, 2025
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 13, 2025
Via Benzinga
Want Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding Stocks
August 13, 2025
Via The Motley Fool
BMY Q2 Deep Dive: Pipeline Progress, Guidance Revision, and Strategic Partnerships Shape Outlook
August 13, 2025
Via StockStory
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
August 11, 2025
Via Benzinga
Topics Lawsuit
PRME Revenue Misses by 73%
August 07, 2025
Via The Motley Fool
Is It Time to Buy Biotech Stocks?
August 06, 2025
Via The Motley Fool
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
August 06, 2025
Via Benzinga
Topics Lawsuit
1 Small-Cap Biotech Stock Poised for a Breakout
August 06, 2025
Via The Motley Fool
Topics Economy
Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)
August 04, 2025
From Bristol Myers Squibb
Via Business Wire
Why Is Replimune Stock Trading Lower On Monday?
August 04, 2025
Via Benzinga

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 47.18
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 08/29/25 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 104.84B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 105B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap